ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

July 1, 2020

Family nurture intervention alters relationships between preterm infant EEG delta brush characteristics and term age EEG power

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Martha G WelchMichael M Myers
July 10, 2020

Progression and survival of patients with motor neuron disease relative to their fecal microbiota

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Shyuan T NgoFrederik J Steyn
July 6, 2020

Motor evoked potentials during revascularization in ischemic stroke predict motor pathway ischemia and clinical outcome

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Tobias GreveKornelia Kreiser
June 13, 2020
Open Access

Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Rosa CapozzoGiancarlo Logroscino
June 20, 2020

A multi-center study of neurofilament assay reliability and inter-laboratory variability

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Elizabeth GrayMarkus Otto
July 4, 2020

Critical illness myopathy as a consequence of Covid-19 infection

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
H TankisiT H Pedersen
July 1, 2020

Central motor conduction time reveals upper motor neuron involvement masked by lower motor neuron impairment in a significant portion of patients with amyotrophic lateral sclerosis

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Ryo TokimuraYoshikazu Ugawa
June 17, 2020

Identifying the epileptogenic zone by four non-invasive imaging techniques versus stereo-EEG in MRI-negative pre-surgery epilepsy patients

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Davide Rossi SebastianoFerruccio Panzica
July 1, 2020

EEG autoregressive modeling analysis: A diagnostic tool for patients with epilepsy without epileptiform discharges

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Chen-Sen OuyangLung-Chang Lin
July 6, 2020
Correction

Corrigendum to "A controlled clinical crossover trial of exercise training to improve cognition and neural communication in pediatric brain tumor survivors" [Clin. Neurophysiol. 131 (2020) 1533-1547

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Elizabeth CoxDonald J Mabbott
June 23, 2020

Temporal regularity of cerebral activity at rest correlates with slowness of reaction times in intellectual disability

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Julie PalixJérôme Favrod
July 4, 2020
Open Access

Concurrent sodium channelopathies and amyotrophic lateral sclerosis supports shared pathogenesis

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
John P FranklinMichael G Hanna
July 1, 2020

Separating posterior-circulation stroke from vestibular neuritis with quantitative vestibular testing

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Zeljka CalicMiriam S Welgampola
June 24, 2020
Open Access

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Madeline KellyKevin Talbot
June 20, 2020

Comment on 'Rapid acquisition of auditory subcortical steady state responses using multichannel recordings'

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Hao LuAndrew J Oxenham
July 1, 2020

Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Carolyn A YoungTONiC study group
June 17, 2020

Beta-band oscillations as a biomarker of gait recovery in spinal cord injury patients: A quantitative electroencephalography analysis

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Marcel SimisFelipe Fregni
July 2, 2020
Open Access

ALSUntangled 57: Vinpocetine

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
ALSUNTANGLED GROUP
July 2, 2020

A prospective study on split-hand index as a biomarker for the diagnosis of amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Zhi-Li WangLiying Cui
July 6, 2020

Validation of an algorithm of time-dependent electro-clinical risk stratification for electrographic seizures (TERSE) in critically ill patients

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
F A CisséN Gaspard

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/als-transposon-de-silencing/678c2a9d-06bc-426b-b1f3-a3e1d44e2440